CRIS Current Research Information System

RUZZI, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.586
EU - Europa 1.142
NA - Nord America 793
AF - Africa 90
SA - Sud America 49
OC - Oceania 1
Totale 3.661
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 782
CN - Cina 624
IT - Italia 596
SG - Singapore 373
VN - Vietnam 294
DE - Germania 131
NL - Olanda 115
HK - Hong Kong 100
KR - Corea 97
IN - India 47
CI - Costa d'Avorio 46
GB - Regno Unito 46
SE - Svezia 44
BR - Brasile 34
FI - Finlandia 33
FR - Francia 32
RU - Federazione Russa 31
CH - Svizzera 24
IE - Irlanda 24
AT - Austria 17
JP - Giappone 17
BG - Bulgaria 11
ID - Indonesia 11
SC - Seychelles 9
TG - Togo 9
MX - Messico 8
DK - Danimarca 7
JO - Giordania 7
UA - Ucraina 7
EG - Egitto 6
ZA - Sudafrica 6
AR - Argentina 5
LT - Lituania 5
PL - Polonia 5
DZ - Algeria 4
MA - Marocco 4
RO - Romania 4
TR - Turchia 4
VE - Venezuela 4
CA - Canada 3
EC - Ecuador 3
HR - Croazia 3
IQ - Iraq 3
MY - Malesia 3
PK - Pakistan 3
LI - Liechtenstein 2
NG - Nigeria 2
PY - Paraguay 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BD - Bangladesh 1
BE - Belgio 1
CL - Cile 1
EE - Estonia 1
GI - Gibilterra 1
GM - Gambi 1
GR - Grecia 1
KG - Kirghizistan 1
LV - Lettonia 1
MU - Mauritius 1
SN - Senegal 1
TN - Tunisia 1
Totale 3.661
Salva come PNG Salva come JPEG
Città #
Singapore 262
Hefei 222
Bologna 203
Shanghai 171
Ashburn 123
Hong Kong 98
Seoul 95
Ho Chi Minh City 76
Hanoi 61
Chandler 57
Milan 49
Fairfield 47
Abidjan 46
Frankfurt am Main 46
Dallas 45
Dong Ket 44
Ann Arbor 37
Beijing 36
Houston 32
Woodbridge 27
Santa Clara 25
Southend 25
Bern 24
Dublin 24
Los Angeles 24
Casalecchio di Reno 22
Boardman 20
Amsterdam 19
Bengaluru 19
Lappeenranta 17
Seattle 17
Council Bluffs 15
Vienna 15
Cambridge 14
Tokyo 14
Wilmington 13
New York 12
Princeton 12
Sofia 11
Guangzhou 10
Helsinki 10
Jakarta 10
Turin 10
Buffalo 9
Falkenstein 9
Lomé 9
Munich 9
Bremen 8
Redmond 8
Amman 7
Berlin 7
Bắc Giang 7
Kerpen 7
Modena 7
Parma 7
Porto Recanati 7
San Giovanni in Persiceto 7
Tongling 7
Vicenza 7
Biên Hòa 6
Can Tho 6
Chicago 6
Crocetta 6
Ha Long 6
Kyiv 6
Moscow 6
Naples 6
Redondo Beach 6
Rome 6
Turku 6
Bo 5
Cimitile 5
Delhi 5
London 5
Nuremberg 5
Rimini 5
São Paulo 5
Chennai 4
Haiphong 4
Hamburg 4
Rancho Palos Verdes 4
Reggio Nell'emilia 4
Saint Paul 4
San Francisco 4
Vũng Tàu 4
Wangen 4
Algiers 3
Bergamo 3
Bexley 3
Boston 3
Boydton 3
Brescia 3
Brooklyn 3
Carrara 3
Castenaso 3
Cento 3
Changsha 3
Des Moines 3
Hyderabad 3
Lấp Vò 3
Totale 2.460
Salva come PNG Salva come JPEG
Nome #
IFN-γ and CD38 in Hyperprogressive Cancer Development 380
Early stability and late random tumor progression of a HER2-positive primary breast cancer patient-derived xenograft 305
Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations 278
Integrated molecular characterization of patient-derived models reveals therapeutic strategies for treating CIC-DUX4 sarcoma 226
Cancer Vaccines Co-Targeting HER2/Neu and IGF1R 213
CD99 contributes to the EWS::FLI1 transcriptome by specifically affecting FOXM1-targets involved in the G2/M cell cycle phase, thus influencing the Ewing sarcoma genetic landscape 195
PD-L1 and IFN-γ modulate Non-Small Cell Lung Cancer (NSCLC) cell plasticity associated to immune checkpoint inhibitor (ICI)-mediated hyperprogressive disease (HPD) 180
Evolution of HER2-positive mammary carcinoma: HER2 loss reveals claudin-low traits in cancer progression 175
Functional evaluation of circulating anti-cancer antibodies with a 3D tumor cell growth inhibition assay 174
ADK-VR2, a cell line derived from a treatment-naïve patient with SDC4-ROS1 fusion-positive primarily crizotinib-resistant NSCLC: a novel preclinical model for new drug development of ROS1- rearranged NSCLC 169
Cancer vaccines: Target antigens, vaccine platforms and preclinical models 154
CRISPR/Cas9-mediated deletion of Interleukin-30 suppresses IGF1 and CXCL5 and boosts SOCS3 reducing prostate cancer growth and mortality 152
Prevention and Therapy of Metastatic HER-2+ Mammary Carcinoma with a Human Candidate HER-2 Virus-like Particle Vaccine 149
Synovial Sarcoma Preclinical Modeling: Integrating Transgenic Mouse Models and Patient-Derived Models for Translational Research 146
Virus-like Particle (VLP) Vaccines for Cancer Immunotherapy 143
Lipid rafts, caveolae, and epidermal growth factor receptor family: friends or foes? 141
Clinical and Preclinical Activity of EGFR Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Harboring BRAF Class 3 Mutations 138
Preclinical activity of ES2B-C001, a human candidate HER-2 virus-like particle (VLP) vaccine, against mammary carcinoma onset and metastasis 114
Targeting PCSK9, through an innovative cVLP-based vaccine, enhanced the therapeutic activity of a cVLP-HER2 vaccine in a preclinical model of HER2-positive mammary carcinoma 102
Chondrosarcoma: New Molecular Insights, Challenges in Near-Patient Preclinical Modeling, and Therapeutic Approaches 86
IL-1 Family Members in Bone Sarcomas 74
Genomic profiling of a collection of patient-derived xenografts and cell lines identified ixabepilone as an active drug against chemo-resistant osteosarcoma 53
5.8S rRNA forms and ribosome heterogeneity in breast cancer 31
Development of cellular models expressing cynomolgus (Macaca fascicularis) HER2 for the functional evaluation of cross-reactive anti-human HER2 response 21
Totale 3.799
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.777
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.777
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021246 0 0 0 0 0 4 26 77 20 15 9 95
2021/2022235 11 13 11 8 21 27 7 22 30 28 35 22
2022/2023373 23 32 20 51 26 32 19 15 52 17 46 40
2023/2024370 16 9 31 27 25 25 17 186 9 12 3 10
2024/20251.030 37 85 68 52 84 51 115 75 25 138 104 196
2025/20261.413 254 421 206 213 216 103 0 0 0 0 0 0
Totale 3.799